News & Events

Children participating in the PETITE study at Tygerberg Hospital, South Africa. *All pictures were taken with permission. The PETITE study, funded by Unitaid as a part of the larger BENEFIT Kids project, aims to expand antiretroviral options for HIV prevention and treatment in neonates.  Compared to adults, the number of antiretroviral drugs with l dosing and […]

#WomenofSU: Negotiating intimacy in a changing HIV landscape Lario Viljoen, sociobehavioural researcher at the DTTC, was featured on the Stellenbosch University website as part of their #WomenofSU initiative during women’s month. Her PhD research on intimacy and HIV highlights the importance and the role of women in this field of study. Please visit the link […]

http://blogs.sun.ac.za/dttc/files/2021/06/CAB-Newsletter-2nd-Edition.pdfCAB Newsletter 2nd Edition

The BENEFIT Kids Project: An update so far The BENEFIT Kids Project, or Better Evidence and Formulations for Improved MDR-TB Treatment for Children, is a Unitaid-funded project aimed at contributing to reduced morbidity and mortality of children with MDR-TB through better access to improved prevention and treatment. The study, launched in 2019, has made remarkable […]

“The SHINE trial is the first tuberculosis treatment-shortening randomised-controlled clinical trial in children. It’s a milestone. We’ve suspected for a long time that we are over-treating many children with TB, but now have clear, pragmatic evidence to inform policy and clinical practice,” said Professor Anneke Hesseling of the Desmond Tutu TB Centre (DTTC) in the […]

On the 9th of December, Unitaid, the funder for the TB CHAMP trial as part of the BENEFIT Kids Project, featured the TB CHAMP study on their website. In the article they highlight the amazing work that has been done as part of the study and introduce some of the dedicated team members who are […]

The PETITE Study, as part of the Unitaid sponsored BENEFIT Kids project, was recently featured on the Stellenbosch University website. As part of the study, researchers from the Desmond Tutu TB Centre are searching for the safest and most effective treatment for babies at high risk of contracting HIV. To read more, please click on […]

HPTN 084 – DSMB Superiority Press Release

Modified Voice Risk Score (MVRS) is a risk assessment tool that is used to determine an individual’s risk of acquiring HIV. The MVRS tool uses 5 standardized questions and assigns a score to each response. The scores are specific to the questions and range from 0 to 2 based on a participant’s response. The scores […]

Original article available: http://www.sun.ac.za/english/Lists/news/DispForm.aspx?ID=7560   Author: FMHS Marketing & Communication / FGGW Bemarking & Kommunikasie – Sue Segar   Dr Karen du Preez, a clinical researcher with the Paediatric TB Research Programme at the Desmond Tutu TB Centre, recently received a grant of nearly R9 million ($540 000) from the National Institutes of Health (NIH) in the United […]